In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.
In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma.
Ke J, Liu Y, Liu F, Cai H, Li X, Zhang Z, Wang N, Shao B, Wang Z, Han M, Ji B.
J Control Release. 2024 Aug;372:141-154. doi: 10.1016/j.jconrel.2024.06.030. Epub 2024 Jun 18.
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.
Adotevi O, Godet Y, Galaine J, Lakkis Z, Idirene I, Certoux JM, Jary M, Loyon R, Laheurte C, Kim S, Dormoy A, Pouthier F, Barisien C, Fein F, Tiberghien P, Pivot X, Valmary-Degano S, Ferrand C, Morel P, Delabrousse E, Borg C.
Oncoimmunology. 2018 Mar 19;7(5):e1424673. doi: 10.1080/2162402X.2018.1424673. eCollection 2018.
Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer.
Qian X, Yang H, Ye Z, Gao B, Qian Z, Ding Y, Mao Z, Du Y, Wang W.
ACS Nano. 2024 Jun 18;18(24):15864-15877. doi: 10.1021/acsnano.4c02947. Epub 2024 Jun 3.
Precise In Situ Delivery of a Photo-Enhanceable Inflammasome-Activating Nanovaccine Activates Anticancer Immunity.
Zhou Y, Pang L, Ding T, Chen K, Liu J, Wu M, Wang W, Man K.
Cancer Res. 2024 Nov 15;84(22):3834-3847. doi: 10.1158/0008-5472.CAN-24-0220.
In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer.
Hatami E, Nagesh PKB, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM.
ACS Appl Bio Mater. 2022 Mar 21;5(3):1104-1119. doi: 10.1021/acsabm.1c01158. Epub 2022 Feb 18.
Electrochemotherapy combined with immunotherapy - a promising potential in the treatment of cancer.
Hadzialjevic B, Omerzel M, Trotovsek B, Cemazar M, Jesenko T, Sersa G, Djokic M.
Front Immunol. 2024 Jan 15;14:1336866. doi: 10.3389/fimmu.2023.1336866. eCollection 2023.
Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma.
Tatarova Z, Blumberg DC, Bensen A, Mills GB, Jonas O.
Cells. 2023 Jan 13;12(2):308. doi: 10.3390/cells12020308.
Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
Xia X, Li X, Feng G, Zheng C, Liang H, Zhou G.
Acta Radiol. 2013 Jul;54(6):684-9. doi: 10.1177/0284185113480072. Epub 2013 Apr 30.
Inflammasome-Activating Nanovaccine for Cancer Immunotherapy.
Zhen W, Chen X.
Cancer Res. 2024 Nov 15;84(22):3709-3711. doi: 10.1158/0008-5472.CAN-24-2905.
Engineering nanotheranostic strategies for liver cancer.
Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW.
World J Gastrointest Oncol. 2021 Oct 15;13(10):1213-1228. doi: 10.4251/wjgo.v13.i10.1213.
